72 related articles for article (PubMed ID: 3133166)
1. Enzyme kinetic studies with beta-lactamases against cefotaxime and other cephalosporins.
Yan SY; Li JT
Chin Med J (Engl); 1987 Dec; 100(12):940-4. PubMed ID: 3133166
[No Abstract] [Full Text] [Related]
2. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
3. beta-Lactamase bioassay: a simplified method to determine extended-spectrum beta-lactamases (ESBL) in enterobacteria.
Silva-Sánchez J; Aguilar-Zacarías C
Arch Med Res; 1997; 28(2):285-7. PubMed ID: 9204623
[TBL] [Abstract][Full Text] [Related]
4. beta-Lactamase stability of some cephalosporins.
Coppi G
Ital J Biochem; 1984; 33(4):280A-285A. PubMed ID: 6439674
[No Abstract] [Full Text] [Related]
5. Antibacterial activity of a new cephalosporin, cefotaxime.
Russell AD; Rogers DT
J Appl Bacteriol; 1980 Aug; 49(1):137-41. PubMed ID: 6253429
[No Abstract] [Full Text] [Related]
6. [Klebsiella oxytoca beta-lactamases: study of their action on 3d-generation cephalosporins].
Labia R; Morand A; Guionie M; Heitz M; Pitton JS
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):611-5. PubMed ID: 3534754
[TBL] [Abstract][Full Text] [Related]
7. Behaviour of cefmenoxime towards beta-lactamases.
Labia R; Morand A; Ben Yaghlane H; Bryskier A
Drugs Exp Clin Res; 1985; 11(6):373-8. PubMed ID: 3939122
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hydrolytic properties of SHV-2 and SHV-1 beta-lactamases, particularly concerning third-generation cephalosporins.
Labia R; Tiwari K; Morand A; Mattioni D; Yaghlane HB; Redjeb SB; Boujenah A
J Chemother; 1989 Jul; 1(4 Suppl):329-30. PubMed ID: 16312425
[No Abstract] [Full Text] [Related]
9. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
10. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
Raquet X; Lamotte-Brasseur J; Fonzé E; Goussard S; Courvalin P; Frère JM
J Mol Biol; 1994 Dec; 244(5):625-39. PubMed ID: 7990143
[TBL] [Abstract][Full Text] [Related]
11. [Detection methods for drug-resistant bacteria in routine examination--ESBL].
Okamoto R
Rinsho Byori; 2000 Jan; Suppl 111():64-8. PubMed ID: 10804794
[TBL] [Abstract][Full Text] [Related]
12. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Jung HI; Song JS; Jeong BC; Kim SJ; Lee SH
Lett Appl Microbiol; 2004; 39(1):41-7. PubMed ID: 15189286
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
14. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
Walther-Rasmussen J; Høiby N
Can J Microbiol; 2004 Mar; 50(3):137-65. PubMed ID: 15105882
[TBL] [Abstract][Full Text] [Related]
15. Emergence of beta-lactam multiresistant variants of gram-negative bacilli in the presence of cefotaxime.
Svarva PL; Lyng RV; Maeland JA
Scand J Infect Dis; 1985; 17(4):387-91. PubMed ID: 3911375
[TBL] [Abstract][Full Text] [Related]
16. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
17. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
Markovska R; Schneider I; Keuleyan E; Bauernfeind A
Clin Microbiol Infect; 2004 Aug; 10(8):752-5. PubMed ID: 15301679
[TBL] [Abstract][Full Text] [Related]
18. Obtainment of SHV-2 beta-lactamase overproducing mutants from Escherichia coli and Klebsiella pneumoniae clinical isolates.
Ben Yaghlane H; Ben Redjeb S; Boujenah A; Philippon A; Labia R
J Chemother; 1989 Jul; 1(4 Suppl):326. PubMed ID: 16312423
[No Abstract] [Full Text] [Related]
19. Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.
Yu Y; Zhou W; Chen Y; Ding Y; Ma Y
Chin Med J (Engl); 2002 Oct; 115(10):1479-82. PubMed ID: 12490091
[TBL] [Abstract][Full Text] [Related]
20. Extended-spectrum and AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae from a rural South Indian tertiary care hospital.
Navaneeth BV
Int J Antimicrob Agents; 2007 May; 29(5):602-3. PubMed ID: 17296286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
